Dhanuka Agritech Ltd management interview: A Steady Q2FY27 For Dhanuka Agritech | Expect Margin Compression Of 125-150 Bps, Says Company
CNBC-TV18, 2026-11-12. Video: https://www.youtube.com/watch?v=3-rE4WqAiN0
- Quarter and growth: September-quarter revenue grew 10% and profit grew by 16% to nearly ₹110 crore. Despite El Niño and a difficult year for agriculture, management expects low single-digit growth, supported by farmer engagement and products aimed at moisture and heat stress.
- Margin outlook: Management expects a margin hit of maybe 150, 125 bps, compared with the 200 bps hit previously anticipated. Cost increases have been passed on to consumers in some areas, but muted demand has prevented full pass-through in others.
- Regional demand: Dhanuka is focusing on crops and areas with strong irrigation prospects and commodity prices. Chilli acreage has risen after two cyclones in Andhra Pradesh, and high commodity prices are expected to add value, especially in insecticides.
- Working capital: Receivables rose from ₹440 crore to around ₹700 crore, while cash flow from operations improved. Management expects cash flow not to be significantly impacted and says inventory has improved and receivables will remain well managed.
- Pipeline and Dahej: Japanese partners are contributing patented-product pipeline opportunities in herbicides and insecticides; Bayer products include Mellididuo and Triadimenol, Iprovalicarb and Triadimenol. Despite sector headwinds, Dhanuka is committed to the Dahej facility and expects to double its revenue next year and probably the year after as well.